vs
Side-by-side financial comparison of Medirom Healthcare Technologies Inc. (MRM) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.
NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $21.1M, roughly 1.7× Medirom Healthcare Technologies Inc.). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -21.3%, a 26.4% gap on every dollar of revenue. NATIONAL RESEARCH CORP produced more free cash flow last quarter ($6.1M vs $-2.4K).
Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
MRM vs NRC — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.1M | $35.2M |
| Net Profit | $-4.5M | $1.8M |
| Gross Margin | 10.8% | — |
| Operating Margin | -28.5% | 13.3% |
| Net Margin | -21.3% | 5.1% |
| Revenue YoY | — | -4.6% |
| Net Profit YoY | — | -72.6% |
| EPS (diluted) | — | $49.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $35.2M | ||
| Q3 25 | — | $34.6M | ||
| Q2 25 | $21.1M | $34.0M | ||
| Q1 25 | — | $33.6M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | — | $35.8M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.3M |
| Q4 25 | — | $1.8M | ||
| Q3 25 | — | $4.1M | ||
| Q2 25 | $-4.5M | $-106.0K | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $6.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 22.4% | ||
| Q2 25 | -28.5% | 4.7% | ||
| Q1 25 | — | 25.6% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | — | 24.8% |
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | -21.3% | -0.3% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 18.0% |
| Q4 25 | — | $49.58 | ||
| Q3 25 | — | $0.18 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $0.26 | ||
| Q1 24 | — | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $252.3K | $4.1M |
| Total DebtLower is stronger | $8.8M | — |
| Stockholders' EquityBook value | $1.6M | $14.0M |
| Total Assets | $52.0M | $134.9M |
| Debt / EquityLower = less leverage | 5.55× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | $252.3K | $5.3M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $3.5M | ||
| Q2 24 | — | $485.0K | ||
| Q1 24 | — | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | $14.3M | ||
| Q2 25 | $1.6M | $21.3M | ||
| Q1 25 | — | $29.7M | ||
| Q4 24 | — | $31.3M | ||
| Q3 24 | — | $34.6M | ||
| Q2 24 | — | $40.2M | ||
| Q1 24 | — | $36.9M |
| Q4 25 | — | $134.9M | ||
| Q3 25 | — | $135.7M | ||
| Q2 25 | $52.0M | $141.4M | ||
| Q1 25 | — | $135.2M | ||
| Q4 24 | — | $132.5M | ||
| Q3 24 | — | $131.8M | ||
| Q2 24 | — | $119.1M | ||
| Q1 24 | — | $120.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.55× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3K | $7.2M |
| Free Cash FlowOCF − Capex | $-2.4K | $6.1M |
| FCF MarginFCF / Revenue | -0.0% | 17.2% |
| Capex IntensityCapex / Revenue | 0.0% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 3.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | $15.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $7.2M | ||
| Q3 25 | — | $13.8M | ||
| Q2 25 | $-2.3K | $-1.1M | ||
| Q1 25 | — | $6.6M | ||
| Q4 24 | — | $6.4M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $12.0M |
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | $-2.4K | $-4.1M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $7.9M |
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 29.4% | ||
| Q2 25 | -0.0% | -12.2% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 22.4% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | 0.0% | 8.8% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 15.0% | ||
| Q1 24 | — | 11.7% |
| Q4 25 | — | 3.99× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRM
| Professional services expense | $20.0M | 95% |
| Other | $1.1M | 5% |
NRC
Segment breakdown not available.
